title: Relevant clinical end points in biphosphonate trials.
authors.forename: J R
authors.initials: JR
authors.lastname: Berenson
authors.forename: P
authors.initials: P
authors.lastname: Major
authors.forename: G
authors.initials: G
authors.lastname: Hortabagyi
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans
chemical_list: D000970:Antineoplastic Agents; D004164:Diphosphonates